⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 17, 2026

IKERVIS 1 mg/ml Augentropfen, Emulsion 1 mg/ml (Augentropfen, Emulsion)

📷 Wikipedia: Ciclosporin · Source
IKERVIS 1 mg/ml Augentropfen, Emulsion 1 mg/ml (Augentropfen, Emulsion)
📷 Wikipedia: Ciclosporin · Source
IKERVIS 1 mg/ml eye drops, emulsion is subject to a parallel export ban.
⚠️
Shortage ongoing
CICLOSPORIN is currently in short supply in AT.
📈 Timeline
85 days active so far
June 19, 2026 September 11, 2026

What is this? This is a medicine called Ikervis. It comes as eye drops. It is used for eye problems.

What's happening? The medicine is not available right now. There is a delay in making it.

Does this affect me? If you use Ikervis eye drops, you may not be able to get them.

What should I do? Ask your pharmacist or doctor for advice. They can help you find another option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
CICLOSPORIN
Agency-published detail

🚫 Parallel export ban active · ATC: S01XA18 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Santen Oy, Niittyhaankatu 20, 33720 Tampere, Republic of Finland · Affected packs: 30 Stück Schachtel, Einzeldosisbehältnis [eingeschränkt verfügbar, since 2026-06-17]

First published
June 17, 2026
Last refreshed by us
1 month ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT resolved 3 months ago

Neoimmun 25 mg - Kapseln 25 mg (Weichkapsel)

Neoimmun 25 mg capsules (soft capsules) 25 mg are unavailable due to a manufacturing delay.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
IKERVIS 1 mg/ml Augentropfen, Emulsion 1 mg/ml (Augentropfen, Emulsion). IKERVIS 1 mg/ml eye drops, emulsion is subject to a parallel export ban.
▸ When was this alert issued?
This alert was issued on June 17, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.